Evidence map›Paper›PMID 31796027›Full record

ArticleRespiratory research2019

Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.

Kang-Jie Li, Zi-Long Chen, Yao Huang, Rui Zhang, Xiao-Qian Luan, Ting-Ting Lei, Ling Chen

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05164692 nacompletednot on this mapstarted 2020, after this paper: background citation

Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Respiratory Syncytial Virus

TypeinterventionalSponsorNational Children's Hospital, VietnamRan2020 to 2021Enrolled100ConditionsAcute Respiratory Tract InfectionsArmsLiveSpo Navax, 0.9% NaCl physiological saline
NCT05474144 nacompletednot on this mapstarted 2021, after this paper: background citation

A Two-arm, Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy of the Probiotic Dietary Supplement SmartProbio C in the Supportive Supplementation of Patients With a Complicated Course of COVID-19 Infection

TypeinterventionalSponsorMedi Pharma VisionRan2021 to 2022Enrolled83ConditionsCOVID-19ArmsSmartProbio C, Placebo
3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kang-Jie LiSchool of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China.
Zi-Long ChenFirst Clinical College, Chongqing Medical University, Chongqing, 400016, China.
Yao HuangFirst Clinical College, Chongqing Medical University, Chongqing, 400016, China.
Rui ZhangSchool of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China.
Xiao-Qian LuanSchool of Public Health and Management, Chongqing Medical University, Chongqing, 400016, China.
Ting-Ting LeiFirst Clinical College, Chongqing Medical University, Chongqing, 400016, China.
Ling ChenThe Center of Experimental Teaching Management, Chongqing Medical University, Chongqing, 401331, China. chenling@cqmu.edu.cn.ORCID http://orcid.org/0000-0003-4391-2432
Chongqing Medical University · CNChongqing Public Health Medical Center · CN

Funding

Chongqing Medical University LTMCMTS201901
6 · The paper itself

Abstract

backgroundLower respiratory tract (LRT) microbiome has been reported to associate with pulmonary diseases. Unregulated inflammation is an underlying cause of variable lung diseases. The lung microbiome may play an important role in the smoking-induced inflammatory lung diseases. What's more, the function of microbiome may be more important for understanding how microbes interact with host. Our study aims to explore the effects of smoking on the lower respiratory tract microbiome, the association between variation of lower respiratory tract microbiome and inflammation and whether smoking exposure changes the function of lower respiratory tract microbime.

methodsForty male mice were randomly divided into smoking group and non-smoking group, and the smoking group was exposed to cigarette smoke for 2 h per day for 90 days. After experiment, the blood samples were collected to measure the concentration of interleukin-6 (IL-6) and C reactive protein (CRP) by ELISA. Lung tissue samples were used to detect the community and diversity of lower respiratory tract microbiome through 16S rRNA gene quantification and sequencing technology. ANOSIM and STAMP were performed to analyze the differences of the microbial community structure between smoking group and non-smoking group. SPSS 24.0 software was used to analyze the correlations between microbiome and inflammation mediators through scatter plots and Spearman correlation coefficient. Microbial metabolic function was predicted by PICRUSt based on the 16 s rRNA gene quantification and sequencing results. PATRIC database was searched for the potential pathogenic bacteria in lower respiratory tract.

resultsOur results suggested that smoking had markedly effects on the microbiota structure of lower respiratory tract based on Bray-Curtis distance (R

conclusionsMembers of Proteobacteria phyla and Firmicutes phyla played an important role in the microbial community composition and keeping a relatively balanced homeostasis. Microbiome dysbiosis might break the balance of immune system to drive lung inflammation. There might exist potential probiotics in lower respiratory tract, such as Lactobacillaceae. The altered function of Lower respiratory tract microbiome under smoking exposure may affect the physiological homeostasis of host.

Indexed as

AnimalsBacteriaBiopsy, NeedleC-Reactive ProteinDisease Models, AnimalDysbiosisEnzyme-Linked Immunosorbent AssayHumansImmunohistochemistryInflammation MediatorsInterleukin-6LungMaleMiceMice, Inbred StrainsMicrobiotaC-Reactive ProteinInflammation MediatorsInterleukin-6SmokeFunction of microbiomeInflammatory mediatorsLower respiratory tractMicrobiomeSmoking

Identifiers

PMID31796027
PMCPMC6892239
OpenAlexW2993153957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.